NorthWest Biotherapeutics Inc (NWBO)

[Fireman02360]

Dennis,

Anavex just submitted a Late-Breaking Abstract for a pivotal Phase 3 Alzheimer's at CTAD on 12/1. They are also do for the pediatric Rett Phase 2 readout which if "meshes" with what the data was with the Adult Rett trial, it will be approved by the FDA. I suspect the soon...Q1 2023. And if PH3 Alz results are superb, $50-75 isn't out of the question, maybe even higher. My point is Anavex isn't that far behind NW Bio and the market in the CNS Bio space is huge, staggering actually. I have owned Anavex since 2015 and made a sizable sum during the intra-day run to $31...had a DCA at one point of $2.15. Sold all above $28, then re-entry with a $9.10 DCA on a huge amount of shares. Anavex has been very, very good too me. What is happenings to NW is no different that what has happened to AVXL...>FUD, AF, Shorts, etc. Things will get straightened out as the market has a funny way of playing catch-up sometime. My suspicions of what has been happening with NWs' SP was confirmed last week. 2 months from the now the picture will look a whole lot different, and I continue to accumulate shares, a lot of shares, until then. Time is all that is needed, and I am not talking about years or months.

-Fireman